Where Global Leaders Meet China's Healthcare Innovators
Register Now
What to Expect
GHIS bridges East and West, connecting international pharmaceutical, medtech, and healthcare companies through curated partnering, transaction roadshows, and strategic networking.
Unrivaled Networking
Connect with 500+ attendees from across the biopharma, medtech, life sciences and investment sectors through 1000+ 1-on-1 meetings.
Cutting-Edge Content
Gain insights from top industry experts on biopharma & medtech trends, investment landscape, market expansion, and cross-border dealmaking.
Investment & Deal-Making Opportunities
Explore funding strategies, IPO potential, and M&A trends shaping APAC’s biopharma & medtech landscape, with 300+ unique companies in attendance and 100+ licensing opportunities.
Global Market Access
Learn how to navigate regulatory pathways and successfully expand into international markets, with participants from all over the world.
Four Tracks. One Ecosystem.
Biopharmaceuticals | Medical Devices | Digital Health & AI | Life Sciences
0
Global Participating Companies
0
GHIS Transaction Roadshows
0
Industry Leaders & Speakers
0
Investment Institutions & Strategic Investors
0
Technology Forums & Panel Discussions
0
1-on-1 Partnering Meetings
Trusted By The Companies Pioneering What's Next
2026 Speakers & Attendees
Industry-leading executives from MNCs, emerging companies, capital firms, and more.
Daniel Nothelfer Vice President, Business Development & Strategy, Life Sciences Innovations Group Danaher
Rogier Janssens President of Merck China and Managing Director of Merck Life Science China Merck
Raju Kucherlapati Paul C. Cabot Professor of Genetics and Professor of Medicine Harvard Medical School
Nicolas Pierre Vice President & General Manager, Life Science and Applied solutions Leica Microsystems
Kaveh Kahen President Abcam
Issei Tsukamoto Senior Vice President, Head of Business Development Astellas Pharma Inc.
Jason Peng Vice President and China Group Executive Danaher
Alex Gu Senior Vice President and President of Greater China Medtronic
June Chang President of Greater China Boston Scientific
Vincent Guercio Head of Strategy, Cytiva Genomic Medicine Danaher
Amit Kakar Managing Partner Novo Holdings Asia
Marie Zhu Chief Technology Officer WuXi XDC
Xiaoping Ye Chairman and Co-founder Tigermed
Xingpeng Wang President Shanghai Hospital Association (SHA)
Chris Chen Chief Executive Officer WuXi Biologics
Guohong Shan SVP, GM, Greater China, Central and South Asia BeOne Medicine
Ling Liu Chief Region Leader Philips Greater China
Lily Dong Vice President & General Manager, China Therapeutics (Mainland and HK, Macau) Abbvie
Shirley Xu CEO, Diagnostics and Healthcare Technology Business Unit Fosun Pharma Group
Sabrina Chan Senior Executive Director HKAPI
Qiang Lyu General Manager Hong Kong and Macau AstraZeneca
Jeffery Li Founding Partner & CEO GL Capital
Michael Yi Founder & Chairman, Co-Chief Investment Officer Hillhouse Investment
Joel Yao Partner Sofinnova Partners - Biovelocita Strategy
Yuesheng Xin Senior Managing Director CITIC Capital
Minnie Fang Chief Scientific Officer, China Danaher
Adam Shen Vice President, Head of M&A Asia Danaher
Robert King Co-Founder and Chief Investment Officer 1540 Ventures
Cui Cui Managing Director and Head of Asia Healthcare Jefferies
Muzi Weng Managing Director, Head of Asia Pharmaceuticals Research Citi
Siai Zhang Head of Business Development, China Tanabe Pharma
Kelly Xia Chief Medical Officer United Family Healthcare
Jinyu Chen Head of Knowledge Transfer Office (Biomedical and Healthcare) The Hong Kong University of Science and Technology (HKUST)
Fred Li Managing Director / Head of University Ventures Gobi Partners
Vincent Ma Chief Executive Officer Hong Kong-Shenzhen Innovation and Technology Park Limited
Peggy Fung President Hong Kong Association of the Pharmaceutical Industry
Dan Liu Managing Partner, China Pivotal bioVenture Partners China
Can Cui Shareholder Greenberg Traurig, LLP.
John Xu Founder and President Biorich International
Yihao Zhang Managing Director Warburg Pincus Asia
Jay Wang CEO EverBridge Group
Sandy Mou Board Executive Director and CEO Corxel
2026 Presenting Companies
Present to a full house of investors and strategics alongside the
CEOs and Founders building technology that is shaping the
future of healthcare.
Plan Your Stay in
Hong Kong
GHIS 2026 HK will be held at Grand Hyatt Hong Kong. In addition to the venue hotel, GHIS will provide registered attendees with access to selected nearby hotels at preferred rates, covering a range of accommodation options to suit different budgets, schedules, and travel preferences.
Learn More
Connecting Global Healthcare
Innovation Beyond the Annual Summit
GHIS is committed to building a connected international platform where innovators, industry leaders,
investors and healthcare organizations can engage throughout the year-not only during the annual
summit, but also at key moments across the global healthcare calendar.
2027
January
J.P. Morgan Healthcare Week
GHIS Satellite Program
June
American Society of Clinical Oncology (ASCO)
GHIS Satellite Program
 
The American Diabetes Association's (ADA's) Scientific Sessions
GHIS Satellite Program
October
Global Healthcare Innovation Summit (GHIS)
Annual Flagship Summit
 
Transcatheter Cardiovascular Therapeutics® Conference (TCT)
GHIS Satellite Program
More to Come
Additional Global Healthcare Conferences
Future GHIS Programs
GHIS 2025 Photo Highlights
GHIS provides a valuable window into emerging healthcare innovation and a highly efficient way to meet companies that are ready for global partnerships.
Head of Search & Evaluation, Global Pharma
GHIS stands out for its ability to connect scientific innovation with industry and capital. It is a valuable platform for companies looking to expand internationally.
Founder, Life Science Company
One of the few events where meaningful partnership discussions can happen in a highly efficient setting.
VP Business Development, Global MedTech